Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation ...

Tickets on sale February 20th NASHVILLE, TN, UNITED STATES, February 12, 2026 /EINPresswire.com/ -- Three distinct and ...

Beyond growth metrics, Atmus Filtration continues to appeal to income-focused investors. The stock began trading ex-dividend ...

The upcoming quarterly reports carry significant weight. They must confirm that the recently reported year-over-year profit growth exceeding 50% was not a one-time anomaly. The publication of Q1 2026 ...